Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Epidural steroid injection in chronic lumbar back pain: a cross-over, single-blinded study of methyl-prednisolone 80mg versus methyl-prednisolone 40mg
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN43299460
Date ISRCTN assigned28/09/2007
Local reference number(s)N0192187922
Public titleEpidural steroid injection in chronic lumbar back pain: a cross-over, single-blinded study of methyl-prednisolone 80mg versus methyl-prednisolone 40mg
Scientific title
AcronymN/A
Disease/condition/study domainMusculoskeletal Diseases: Low back pain
Study hypothesisDoes 40mg of epidural methyl-prednisolone produce an equivalent improvement in disability scores when compared to 80mg of epidural methyl-prednisolone?
Design/methodologyRandomised, single-blinded, cross-over trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients attending Nottingham City Hospital Day Case Unit, with chronic back pain who are presenting for repeat epidural steroid injection as part of their chronic pain management programme.
Participants - exclusion criteriaBlood clotting disorder, anticoagulant (Warfarin) use.
Patient information material
Anticipated start date24/05/2006
Anticipated end date28/02/2007
Status of trialCompleted
Target number of participants60
InterventionsRandomised, single-blinded, cross-over trial with two treatment arms:
1. 80mg methyl-prednisolone repeated three months later with 40mg dose
2. 40mg methyl-prednisolone repeated three months later with 80mg dose
Primary outcome measure(s)Evidence that a reduced dose of methyl-prednisolone given epidurally does not cause a significant worsening of the primary outcome measure ie the Oswestry Low Back Pain Disability Index.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNottingham University Hospitals NHS Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr A Ravenscroft
Contact detailsAnesthetics Department
City Hospital
Hucknall Road

Nottingham
United Kingdom
NG5 1PB
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN43299460
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central